Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tonga Tech Press.
Press releases published on July 2, 2025
PharmaTher Announces Path to Ketamine Commercialization with No Planned Financing, Confirms FDA Approval Goal Date of August 9th, 2025 for Ketamine
GlobeNewswire
·
July 2, 2025
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on the development and commercialization of ketamine-based pharmaceuticals, is …
Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc.
GlobeNewswire
·
July 2, 2025
Name change reflects company’s leadership position with its cryptocurrency treasury reserve strategy focused on the HYPE token Company to commence trading on Nasdaq under the symbol “HYPD” effective July 3rd Also announces official launch of the Kinetiq x …
NowVertical’s Integration Strategy Accelerates Account Expansion and Cross-Market Growth
GlobeNewswire
·
July 2, 2025
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) (“NowVertical” or the “Company”), a leading data and AI solutions provider, today provided an update on the execution of its “One Brand, One Business” integration strategy, …
GDS Announces the Final Offering Price for its C-REIT Initial Public Offering on the Shanghai Stock Exchange
GlobeNewswire
·
July 2, 2025
SHANGHAI, China, July 02, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that the final offering …
VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202
GlobeNewswire
·
July 2, 2025
BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune- …
BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven
GlobeNewswire
·
July 2, 2025
Together, Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven add 30 satellite locations to enroll patients in BriaCell’s pivotal Phase 3 study BriaCell’s Phase 3 study currently has 58 active clinical sites across 15 states, including …
BSTR Miner Launches SOL Cloud Mining Contracts with Unprecedented Demand
GlobeNewswire
·
July 2, 2025
New York City, NY, July 02, 2025 (GLOBE NEWSWIRE) -- With SOL prices set to see a major breakout, investors are flocking to leading AI cloud mining platform BSTR Miner as demand for its newly launched SOL mining contracts surges. Market analysts are …
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
GlobeNewswire
·
July 2, 2025
CLEVELAND, July 02, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the closing of the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $155 million on June 27, 2025. Including net …
ZenaTech Expands Drone as a Service (DaaS) to California with Offer to Acquire an Engineering and Surveying Firm, Tapping into Precision Agriculture and Viticulture Market
GlobeNewswire
·
July 2, 2025
VANCOUVER, British Columbia, July 02, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), and enterprise SaaS, has …
Invivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID and COVID-19 Post-Vaccination Syndrome
GlobeNewswire
·
July 2, 2025
SPEAR Study Group initiated following multiple, independent reports of substantial clinical benefit associated with PEMGARDA® (pemivibart) therapy among people with Long COVID SPEAR Study Group collaborators Drs. Michael Peluso, Amy Proal, and David …
Mozart AI Empowers Music Producers With AI Co-Production
GlobeNewswire
·
July 2, 2025
London, July 02, 2025 (GLOBE NEWSWIRE) -- 85% of music today never gets released. London-based Mozart AI has raised $730K in pre-seed funding to solve this problem with the world's first AI-powered Digital Audio Workstation (DAW) that accelerates music …
Dayforce Empowers Canadian Small and Mid-Sized Businesses with Powerpay by Dayforce
GlobeNewswire
·
July 2, 2025
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced the rebranding of its payroll and HR solution for Canadian small and mid-sized …
Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
GlobeNewswire
·
July 2, 2025
Pelthos plans to launch ZELSUVMI™ for the treatment of Molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, Ligand has invested $18 million in the combined company and is entitled to a 13% royalty on worldwide sales of …
Water Ways Technologies Enters Strategic Partnership for Exclusive Tomato Hybrid Development for Vertical Farming
GlobeNewswire
·
July 2, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Water Ways Technologies Inc. (TSX-V: WWT) (“Water Ways” or the “Company”), a leading provider of advanced agricultural …
Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
GlobeNewswire
·
July 2, 2025
The combined company plans to launch ZELSUVMI™ for the treatment of molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, the combined company closed on a $50.1 million equity private placement Combined company will …
Crypto Losses Surpass $2.47 Billion in H1 2025, CertiK Report Reveals Alarming Rise in Phishing Attacks
GlobeNewswire
·
July 2, 2025
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- CertiK, the world’s largest Web3 security service provider, released its Web3 security quarterly report, Hack3d, for Q2 and H1 2025, revealing that more than $2.47 billion has been lost to hacks, scams, and …
CertiK, ‘Hack3d’ 보안 보고서 발표: 2025년 상반기 손실액 작년 연간치 넘어…피싱 공격이 주요 원인
GlobeNewswire
·
July 2, 2025
뉴욕, July 02, 2025 (GLOBE NEWSWIRE) -- 글로벌 최대 Web3 보안 기업 CertiK이 최신 ‘Hack3d: 2025년 2분기 및 상반기 Web3 보안 보고서’를 발표했다. 보고서에 따르면 2025년 상반기 발생한 보안 사고로 인한 손실액은 약 25억 달러에 달하며, 이는 이미 작년 한 해 전체 손실액을 넘어선 수치다. 전반적으로 Web3 보안 상황은 여전히 심각하며, 공격 방식 또한 지속적으로 진화하고 있다. 보고서에 따르면, …
CertiK发布Hack3d报告：2025上半年损失金额已超去年全年，钓鱼攻击成主因
GlobeNewswire
·
July 2, 2025
纽约, July 02, 2025 (GLOBE NEWSWIRE) -- 据官方消息，全球最大的Web3安全公司CertiK最新发布了《Hack3d：2025年第二季度及上半年Web3安全报告》。报告指出，仅2025年上半年，因安全事件导致的损失近25亿美元；截至目前，总损失已超过去年全年水平。整体来看，Web3安全形势依然严峻，且威胁手段仍在不断演化升级。 报告还指出，第二季度损失金额约8亿美元，若仅计算确认无法追回的净损失（不包括白帽追回及被冻结资金），2025年目前已累计损失22.9 …
Dayforce offre aux PME canadiennes les moyens de réussir grâce à Powerpay par Dayforce
GlobeNewswire
·
July 2, 2025
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE : DAY; TSX : DAY), un chef de file mondial en gestion du capital humain qui améliore la vie au travail, a annoncé aujourd’hui le repositionnement de marque de sa solution de gestion de la paie …
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism
GlobeNewswire
·
July 2, 2025
AUSTIN, TX and DURHAM, NC, July 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the …